Drugs / IOP Injection
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03399214 | Apr → May 2018 | — | MegaPro Biomedical Co. Ltd. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | IOP Injection | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03399214 ↗ |
| Route | Intravenous | “IOP Injection intravenous administration” NCT03399214 ↗ |